Gene Query: BCAN

Dataset Description Geneva Score
RNA sequencing of BT142 and TS603 cell lines 103.64
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 103.64
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 102.89
RNA-seq analysis of uveal melanoma cells treated with FR900359 85.27
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 69.77
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 66.05
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 62.74
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 60.26
Effect of disulfiram treatment on pediatric high grade glioma 57.39
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 54.72
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 52.74
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 51.9
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 48.19
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 47.83
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 43.86
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 43.86
Gene expression changes in human melanoma cell lines compared to primary melanocytes 40.34
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 37.68
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 37.39
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 35.36
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 33.35
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 32.7
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 31.51
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 31.44
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 31.44
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 31.43
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 31.29
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 31.29
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 31.26
Regionally specified human pluripotent stem cell-derived astrocytes 28.67
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 27.23
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 26.5
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 26.11
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 26.11
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 25.21
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 25.21
Disruption of GRIN2B impairs differentiation in human neurons 23.59
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 23.09
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 22.63
Functional astrocytes differentiated from hiPSCs 20.81
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 20.56
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 20.26
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 20.26
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 18.14
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 18.14
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 18.13
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 16.66
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 16.66
Transcriptional profiling of microglia; current state of the art and future perspectives 16.57
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 15.92
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 15.56
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 15.56
circRNA-sequencing 15.51
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 15.03
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 14.67
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 14.67
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 14.34
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 13.84
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 13.81
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 13.51
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 13.03
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 12.36
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 11.82
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 11.52
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 11.44
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 11.42
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 11.38
Efficient derivation of microglia-like cells from human pluripotent stem cells 11.37
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 11.36
RNA seq with AML (NB4) cells upon FTO inhibition 11.19
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 10.76
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 10.76
Repurposing of promoters and enhancers during mammalian evolution 10.48
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 10.46
The pause-initiation limit restricts transcription activation in human cells 10.27
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 10.27
Epigenomic landscape during organ formation in human early embryos 10.18
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 10.17
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 10.12
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 9.92
Comparing gene expression in iPSC derived RPE from control and AMD donors 9.77
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 9.43
Examining serotonergic neuron differentiation from human iPSCs 9.31
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 8.93
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 8.76
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 8.72
Transcriptional responses of melanoma cells to BRAF inhibition 8.53
Transcriptional dependencies in diffuse intrinsic pontine glioma 8.5
Dissecting neural differentiation regulatory networks through epigenetic footprinting 8.44
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 8.41
FOXP1 orchestration of ASD-relevant signaling pathways. 8.4
4sUDRB-seq: measuring transcription elongation and initiation genomewide 8.36
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 7.53
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 7.52
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 7.03
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 7.03
CUREfast: Accelerating research with families 6.95
Proteomics identifies a marker signature of MAPKi resistance in melanoma 6.63
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 6.56
LncRNA-GAS5 negative regulation of YAP-target genes expression 6.37
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 6.32
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 6.18
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 6.07
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 6.05
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 5.97
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 5.85
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 5.85
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 5.71
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 5.63
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 5.4
The DNA methylation landscape of human melanoma 5.34
The DNA methylation landscape of human melanoma [RNA-Seq] 5.34
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 5.33
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 5.32
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 5.31
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 5.19
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 5.19
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 5.1
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 5.1
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 4.92
Recovery and analysis of nascent RNA 4.92
Universal alternative splicing of noncoding exons 4.91
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 4.89
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 4.85
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 4.85
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 4.8
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 4.8
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 4.73
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 4.69
LINE-2 transposable elements are a source of functional human microRNAs and target sites 4.66
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 4.57
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 4.57
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 4.56
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 4.49
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 4.47
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 4.43
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 4.36
Primate-specific gene TMEM14B promotes cortical expansion and folding 4.3
Genome-wide discovery of human splicing branchpoints 4.29
U1 snRNP telescripting regulates size-function stratified human genome 4.2
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 4.09
Genome-wide identification of cancer-specific alternative splicing in circRNA 3.97
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 3.96
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 3.87
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 3.87
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 3.74
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 3.74
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 3.74
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 3.74
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 3.73
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 3.69
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 3.62
R430: A potent inbibitor of DNA and RNA viruses 3.59
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 3.51
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 3.51
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 3.47
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 3.47
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 3.44
RNA-seq melanoma 3.41
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 3.37
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 3.33
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 3.32
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 3.29
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 3.18
Transcriptional effect of ETV1 knockdown in melanoma cells 3.17
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 3.04
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 3.0
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 2.98
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 2.96
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 2.93
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 2.9
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 2.9
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 2.87
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 2.78
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 2.74
The regulartory role of ZCCHC24 in splicing machinery 2.73
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 2.66
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 2.61
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 2.56
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 2.44
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 2.4
iPSC derived motor neuron cultures from C9ORF72 carriers 2.39
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 2.39
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 2.33
Human optic chiasm from healthy controls and multiple sclerosis patients 2.32
Multiple sclerosis and EAE 2.32
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 2.3
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 2.29
SF3B1 Degron knockdown RNA-seq 2.28
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 2.26
Molecular analysis of renal cell carcinoma with unclassfied histology 2.26
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 2.26
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 2.24
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 2.22
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 2.16
Activity-dependent transcriptional changes in human neurons 2.14
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 2.13
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 2.11
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 2.11
Gene expression profile of multiple myeloma cell lines treated with CB-5083 2.08
The role of FAM46C in myeloma cells 2.08
The role of FAM46C in myeloma cells [sequencing] 2.08
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 2.08
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 2.07
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 2.04
Differential gene expression of human melanoma cells [RNA-seq] 2.04
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 1.96
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 1.95
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 1.91
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 1.89
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 1.88
mRNA expression profile of Lymphocytes by high-throuput sequencing 1.88
Global response to chemotherapy-induced apoptosis 1.82
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 1.78
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 1.73
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 1.71
RNA sequencing of human mammary epithelial cells 1.7
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 1.68
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 1.66
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 1.65
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 1.64
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 1.64
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 1.62
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 1.61
Accurate annotation of human protein-coding small open reading frames 1.61
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.58
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.58
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 1.58
CD86 regulates a pro-survival signal in myeloma cells 1.57
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 1.56
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 1.54
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 1.53
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 1.44
NRDE2 negatively regulates nuclear exosome functions 1.43
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 1.43
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 1.39
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 1.39
Knockdown of ADNP in HCT116 colon cancer cells 1.37
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 1.36
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 1.36
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 1.33
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 1.33
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 1.29
Global epigenomic reconfiguration during mammalian brain development 1.26
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 1.25
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 1.22
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 1.18
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 1.18
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 1.17
Genome-wide analysis of Dengue virus 2 infected cells 1.17
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 1.15
EWSR1 influences alternative splicing through direct and indirect mechanisms 1.14
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 1.13
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 1.13
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 1.12
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 1.12
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 1.12
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 1.12
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 1.11
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 1.1
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 1.08
JAK dependent survival of ALK- ALCL 1.08
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 1.07
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 1.07
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 1.06
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 1.05
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 1.05
RNA-seq of tumor cells following angiopellosis extravasation 1.05
Chromatin-informed inference of transcriptional programs in gynecologic cancers 1.03
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 1.03
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 1.02
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 1.01
Patient-derived xenograft platform for metastatic melanoma 1.0
Effect of FGF13 depletion on the H460 cell line 1.0
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.0
TGF-β promotes genomic instability after loss of RUNX3 0.99
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 0.98
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 0.98
The landscape of alternative splicing in aggressive prostate cancers 0.98
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 0.97
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 0.96
TT-Seq captures the human transient transcriptome 0.96
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.95
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.95
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 0.95
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 0.95
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 0.94
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.94
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 0.94
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 0.94
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 0.93
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 0.93
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 0.93
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 0.93
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 0.92
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 0.92
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 0.92
RNA-Sequencing of HepG2 cells treated with TGFBeta 0.91
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 0.91
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 0.9
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 0.9
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 0.9
Differentially expressed genes post knock down of lincDUSP26 0.9
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 0.89
Differetially expressed genes after hTR overexpression in U2OS cells 0.89
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 0.89
The Glioma-Infiltrating T Cell Receptor Repertoire 0.88
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 0.88
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 0.87
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 0.87
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 0.87
RNA-seq of RKO cells with cTAZ KO or putback 0.86
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 0.86
SRSF2 mutations impair hematopoiesis and alter exon recognition 0.86
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 0.85
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 0.85
RNA editing in nascent RNA affects pre-mRNA splicing 0.85
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.85
Gene expression in GBM with Cav3.2 inhibition 0.85
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.84
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 0.83
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 0.82
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 0.82
hTERT promotes cell adhesion and migration independent of telomerase activity 0.82
RNAseq in Alzheimer's Disease patients 0.81
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.8
A role for ZNF598 in post-transcriptional gene regulation 0.8
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 0.79
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 0.79
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 0.79
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 0.79
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 0.78
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 0.78
Transcriptome analysis of BAP1 knockout and restoration 0.78
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 0.78
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 0.78
RNA-seq analysis to identify the genes regulated by p53-SET interplay 0.77
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 0.75
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 0.74
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 0.74
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 0.74
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 0.73
PRDM1 inhibits proliferation of human colon cancer organoids 0.73
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 0.72
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 0.72
Illumina Total RNA-seq in HeLa 0.72
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.72
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 0.7
RNA-seq in endometrial stromal tumors 0.7
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 0.7
ARID1A and ARID1B loss in HCT116 cells 0.68
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 0.66
RNA sequencing of human pancreatic cancer cell lines 0.66
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.66
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.66
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 0.65
Transcriptome analysis in Neobractatin treated cells 0.64
RNA splicing alteration on glioblastoma and normal neural stem cells 0.64
iPSC-Derived Cholangiocytes 0.64
HEK293 Heat-shock experiment 0.63
ENCODE Cold Spring Harbor Labs Long RNA-seq 0.62
Transcriptome-wide identification of CELF2 functional targets in T cells 0.62
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 0.62
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 0.62
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 0.62
The age and genomic integrity of neurons after cortical stroke in humans 0.62
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 0.61
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 0.6
Differential gene expression profiles in imatinib-resistant cell lines 0.58
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 0.58
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 0.56
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 0.56
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 0.56
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 0.56
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 0.56
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 0.54
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 0.54
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 0.53
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 0.53
Nonpregnant and term pregnant human myometrial tissues 0.52
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 0.52
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 0.51
Gene Expression Profiling of WT and KDM3A Knocked out Cell 0.51
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 0.51
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 0.51
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 0.5
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.48
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.48
Alteration of the microRNA network during the progression of Alzheimer’s disease 0.47
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 0.47
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 0.47
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 0.47
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 0.47
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 0.47
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 0.47
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 0.45
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 0.45
HEXIM1 is induced by DHODH inhibition to suppress melanoma 0.45
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 0.45
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 0.42
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 0.42
Searching for target genes of miR-508/509/506/514 in HCT116 cells 0.41
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 0.41
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 0.41
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 0.39
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 0.39
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 0.39
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 0.39
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 0.39
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 0.39
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 0.38
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 0.38
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.38
An acquired vulnerability of drug resistant melanoma with therapeutic potential 0.38
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 0.38
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 0.38
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.38
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 0.37
Identification of long noncoding RNAs regulated by p53 0.35
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 0.35
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.34
Genome-wide discovery of human splicing branchpoints [RNAse] 0.34
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 0.34
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 0.33
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 0.33
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 0.33
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 0.32
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 0.31
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.31
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 0.3
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 0.3
Enhancer activation during EGF response 0.3
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 0.29
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 0.29
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 0.28
Epigenomic conservation of transposable element silencing 0.27
Epigenomic conservation of transposable element silencing [RNA-seq] 0.27
Transposon-based construction of strand-specific RNA-seq libraries 0.26
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 0.26
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 0.25
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 0.25
CSL RNA-Seq on HKC and SCC cell lines 0.25
CSL 0.25
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 0.25
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.24
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.24
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 0.24
Myc activation coordinates gene transcription and protein translation responses 0.24
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 0.24
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.24
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 0.24
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 0.24
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 0.24
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 0.22
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.21
K562 polyA RNA-Seq 0.21
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 0.2
Targeted enhancer activation by a subunit of the integrator complex 0.2
UV_24h_GRO-Seq 0.2
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 0.2
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 0.19
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 0.19
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.18
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 0.17
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 0.17
U2AF1 mutations alter splice site recognition in hematological malignancies 0.16
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 0.15
ARID1A and ARID1B loss in HCT116 and TOV21G cells 0.15
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 0.14
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.14
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 0.14
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 0.14
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 0.13
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 0.13
Widespread regulated alternative splicing of single codons accelerates proteome evolution 0.12
DRB/GRO-Seq -/+ UV 0.12
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 0.12
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.11
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 0.11
Functional Haploid Human Oocytes Generated from Polar Body Genomes 0.11
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.11
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.1
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.1
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 0.1
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.09
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 0.08
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 0.08
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 0.07
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.06
Exploring ILF2 regulatory genes by next-generation sequencing 0.05
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 0.05
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 0.05
RNA-Seq of the corpus callosum from 12 individuals 0.05
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.04
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.03
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.02
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 0.02
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 0.01
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 0.01
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation